Healthcare stocks have been doing well lately, even though healthcare is recognized as one of the more defensive market sectors. For the past year, the group is up nearly 33%, as measured by the Healthcare SPDR ETF (NYSE: XLV). Against the SPDR S&P 500 ETF (NYSE: SPY), which gained nearly 50% for the year, healthcare's rise is noteworthy, especially with speculation about how the new reforms will impact the industry. Furthermore, investors should note that generally corporations in the healthcare industry carry smaller price-to-earnings (P/E) ratios than those in other sectors.

IN PICTURES: World's Greatest Investors

Year to date, the rise has been nearly 4% as compared to the broad market's 5.35% increase for the same period. Below, we highlight three healthcare performers who stand out from a fundamental value perspective.

Vaccines That Pay

Sanofi-Aventis SA (NYSE: SNY) is a Paris-based pharmaceutical giant that specializes in vaccine production. The company's shares have risen by almost 36% in the past year and currently trade with a dividend yield of 4.37%. The present P/E ratio is 13.78, and the market cap is just a tad lower than $100 billion.

Last month, Sanofi-Aventis completed its acquisition of Chattem, thereby acquiring several popular American health-related brands and gaining a solid base from which to grow in the U.S. The deal was worth $1.9 billion and includes the well-known Gold Bond and Selsun Blue products.

Second Pharma Giant Also Acquiring

Pfizer (NYSE: PFE) is another healthcare heavyweight, with a market cap in excess of $139 billion and a business that's focused in a number of different areas including pharmaceuticals, human and animal vaccines as well as a well-known line of consumer healthcare products.

In the last year, Pfizer shares were up 26%. They currently trade with a multiple of 12.73 times last year's earnings and carry a yield of 4.17% per annum.

Grupo Casa Saba SA (NYSE: SAB) is a Mexican distributor of health, beauty and pharmaceutical products. Last year the company's stock gained 25%. It currently sports a 2.95% annual dividend and trades with a competitive P/E of just 10.97.

SAB's price-to-book ratio is also attractive at 0.82, significantly below the industry and broader S&P 500. The company's market cap is $437 billion.

The Wrap

Healthcare shares are largely defensive plays, like utilities and telecoms, and those issues that carry strong dividends offer even more safety to investors concerned about the bull market's sustainability. The above three stocks lead the healthcare sector, offering some of the best fundamentals that group has to offer. (To learn about implications of the new healthcare reforms, refer to 10 Ways The New Healthcare Bill May Affect You.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Mutual Funds & ETFs

    The 3 Biggest Mutual Fund Companies in the US

    Compare and contrast the rise of America's big three institutional asset managers: BlackRock Funds, The Vanguard Group and State Street Global Advisors.
  2. Stock Analysis

    3 Stocks that Are Top Bets for Retirement

    These three stocks are resilient, fundamentally sound and also pay generous dividends.
  3. Professionals

    5 Top-Rated Funds for Your Retirement Portfolio

    Mutual funds are a good choice for emotional investors. Here are five popular funds to consider.
  4. Investing News

    Are Stocks Cheap Now? Nope. And Here's Why

    Are stocks cheap right now? Be wary of those who are telling you what you want to hear. Here's why.
  5. Investing News

    4 Value Stocks Worth Your Immediate Attention

    Here are four stocks that offer good value and will likely outperform the majority of stocks throughout the broader market over the next several years.
  6. Investing News

    These 3 High-Quality Stocks Are Dividend Royalty

    Here are three resilient, dividend-paying companies that may mitigate some worry in an uncertain investing environment.
  7. Stock Analysis

    An Auto Stock Alternative to Ford and GM

    If you're not sure where Ford and General Motors are going, you might want to look at this auto investment option instead.
  8. Mutual Funds & ETFs

    The 4 Best Buy-and-Hold ETFs

    Explore detailed analyses of the top buy-and-hold exchange traded funds, and learn about their characteristics, statistics and suitability.
  9. Chart Advisor

    Bumpy Roads Ahead In Transportation

    Investors are keeping an eye on the transportation industry. We'll take a look at the trend direction and how to trade it.
  10. Investing

    How ETFs May Save You Thousands

    Being vigilant about the amount you pay and what you get for is important, but adding ETFs into the investment mix fits well with a value-seeking nature.
  1. Are Cafeteria plans exempt from Social Security?

    Typically, qualified benefits offered through cafeteria plans are exempt from Social Security taxes. However, certain types ... Read Full Answer >>
  2. Can your insurance company cancel your policy without notice?

    In most states, an insurance company must give a policyholder written notice of at least 30 days before canceling a policy. ... Read Full Answer >>
  3. How do I calculate insurance premium tax?

    In the United States, consumers do not pay any additional tax on health insurance premiums. However, your insurance premiums ... Read Full Answer >>
  4. Can your insurance company drug test you?

    Insurance companies have the right to require drug tests for health insurance and life insurance policies, but not all of ... Read Full Answer >>
  5. What is the difference between a peril and a hazard?

    The two related terms "peril" and "hazard" are often used in reference to the insurance industry. Essentially, a peril is ... Read Full Answer >>
  6. Can mutual funds invest in IPOs?

    Mutual funds can invest in initial public offerings (IPOS). However, most mutual funds have bylaws that prevent them from ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!